Workflow
Chemclin Diagnostics(688468)
icon
Search documents
科美诊断(688468) - 2021 Q1 - 季度财报
2021-04-28 16:00
Financial Performance - Operating income rose by 103.52% to CNY 120,215,653.37 year-on-year[5] - Net profit attributable to shareholders increased by 253.69% to CNY 38,138,994.23 compared to the same period last year[5] - Basic and diluted earnings per share both increased by 253.69% to CNY 0.11[5] - Operating profit for Q1 2021 was ¥44,471,576.60, up from ¥12,962,487.05 in Q1 2020, reflecting a growth of 243.5%[30] - Net profit for Q1 2021 amounted to ¥38,138,994.23, compared to ¥10,783,085.91 in Q1 2020, representing an increase of 253.5%[30] Cash Flow - Net cash flow from operating activities surged by 817.53% to CNY 40,023,264.03 year-on-year[5] - Cash flow from operating activities for Q1 2021 was ¥40,023,264.03, a substantial increase from ¥4,362,069.13 in Q1 2020[38] - The net cash flow from operating activities was -¥1,011,888.80, improving from -¥12,210,391.01 in the same period last year[40] Assets and Liabilities - Total assets increased by 7.31% to CNY 1,080,465,148.40 compared to the end of the previous year[5] - Total liabilities rose to CNY 154,967,598.90 from CNY 119,463,997.34, which is an increase of approximately 29.7%[22] - The company's total liabilities included a new lease liability of ¥29,298,095.26, reflecting the impact of new leasing regulations[15] - The company's current assets totaled CNY 745,371,829.51, compared to CNY 702,339,971.46 at the end of 2020, indicating an increase of about 6.1%[20] Research and Development - R&D expenses accounted for 12.25% of operating income, a decrease of 5.74 percentage points from the previous year[7] - Research and development expenses increased by 38.57% to ¥14,728,188.25, up from ¥10,628,422.89, reflecting the company's commitment to innovation[15] - R&D expenses increased to ¥7,879,358.05 in Q1 2021, up from ¥5,557,862.73 in Q1 2020, reflecting a focus on innovation[33] Shareholder Information - The total number of shareholders at the end of the reporting period was 16[10] - The largest shareholder, Ningbo Free Trade Zone Yingweili Enterprise Management Partnership, holds 30.00% of shares[10] Other Financial Metrics - The weighted average return on equity rose by 2.97 percentage points to 4.21%[5] - The company reported a total of CNY 1,508,107.19 in non-recurring gains and losses[9] - The company reported a substantial increase in income tax expenses, which rose by 450.86% to ¥6,254,697.46 from ¥1,135,442.34[15] - Investment income decreased by 59.79% to ¥1,385,096.96, down from ¥3,444,391.01, indicating a decline in returns from financial products[15] Changes in Assets - Other current assets rose significantly by 95.34% to ¥14,078,698.19, compared to ¥7,207,299.59 in the previous period[15] - The company's inventory increased to CNY 107,312,731.75 from CNY 98,672,713.99, marking an increase of about 8.3%[20] - The company reported a non-current asset total of CNY 335,093,318.89, up from CNY 304,482,581.14, indicating an increase of about 10.1%[21] Compliance and Standards - The company implemented a new leasing standard starting in 2021, affecting the financial statements[42] - The company adopted the new leasing standard effective January 1, 2021, which did not significantly impact financial status or cash flows[47]